MindMaze expands into home neurorehabilitation with MindHome wearable VR system
Summary
Swiss neurorehabilitation company MindMaze launched MindHome, a consumer-accessible VR neurorehabilitation system for post-stroke and TBI patients continuing therapy at home after hospital discharge. The system pairs a Meta Quest 3 headset with MindMaze's proprietary motion tracking and adaptive difficulty algorithms, priced at $149/month subscription with 30-day free trial.
Why it matters
Home neurorehabilitation at $149/month addresses the fundamental access problem of stroke rehab — most patients receive 30-60 hours of inpatient therapy but need hundreds of hours for optimal recovery. MindMaze's hospital-to-home continuum of care model is the most commercially ambitious neurorehabilitation product launch of 2024.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial